title: Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome.
authors: E
authors: E
authors: Kapiteijn
authors: A
authors: A
authors: Brand
authors: J
authors: J
authors: Kroep
authors: H
authors: H
authors: Gelderblom
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D007211:Indoles / Q000009:adverse effects*; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced*; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000037:antagonists & inhibitors
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D042461:Vascular Endothelial Growth Factor A; D040301:Vascular Endothelial Growth Factor Receptor-2; D000077210:Sunitinib